Clinical Trial Update: Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study [Phase 4]

View source ↗

Summary

This Phase 4 trial updates a switch study comparing etanercept and adalimumab in ankylosing spondylitis. The status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• ENBREL (etanercept)
• Humira (adalimumab)

Snippet

Sponsor: Chung Shan Medical University | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN